Non-Current Assets
Long-term investments
Merck & Co. Long-term investments increased by 5.1% to $956M in Q4 2025 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2024
Last reportedQ4 2025Feb 24, 2026
How to read this metric
An increase may signal strategic expansion or capital deployment, whereas a decrease could indicate divestment or the liquidation of assets to fund operations.
Detailed definition
These are assets that the company intends to hold for more than one year, including long-term securities, strategic inve...
Peer comparison
Large pharmaceutical firms often hold significant long-term investments in biotech startups or joint ventures.
Metric ID:
long_term_investmentsHistorical Data
2 periods
| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | $910M | $956M |
| QoQ Change | — | +5.1% |
| YoY Change | — | +5.1% |
Range$910M – $956M
Avg YoY Growth+5.1%
Median YoY Growth+5.1%
Long-term investments at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s long-term investments?
- Merck & Co. (MRK) reported long-term investments of $956M in Q4 2025.
- What does long-term investments mean?
- Investments and assets that the company plans to hold for longer than one year.